These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32838804)

  • 1. Effects of neurohormonal antagonists on blood pressure in patients with heart failure with reduced ejection fraction (HFrEF): a systematic review protocol.
    Guggilla RK; Sowa PM; Jamiolkowski J; Sinnadurai S; Amin A; Kaminski KA
    Syst Rev; 2020 Aug; 9(1):194. PubMed ID: 32838804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy and acceptability of Chinese herbal medicine in adult patients with heart failure and reduced ejection fraction: study protocol for a systematic review and network meta-analysis.
    Liu J; Lu JJ; Zhou K; Wan J; Li Y; Cui XY; Gao Q; Huang YC; Li SN; Dong QZ; Lin Q
    BMJ Open; 2018 Jun; 8(6):e015678. PubMed ID: 29921675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of drug interventions to prevent sudden cardiac death in patients with heart failure and reduced ejection fraction: an overview of systematic reviews.
    Al-Gobari M; Al-Aqeel S; Gueyffier F; Burnand B
    BMJ Open; 2018 Jul; 8(7):e021108. PubMed ID: 30056380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do adrenergic alpha-antagonists increase the risk of poor cardiovascular outcomes? A systematic review and meta-analysis.
    Sousa JP; Mendonça D; Teixeira R; Gonçalves L
    ESC Heart Fail; 2022 Oct; 9(5):2823-2839. PubMed ID: 35894772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis.
    Berbenetz NM; Mrkobrada M
    BMC Cardiovasc Disord; 2016 Dec; 16(1):246. PubMed ID: 27905877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
    Turgeon RD; Kolber MR; Loewen P; Ellis U; McCormack JP
    PLoS One; 2019; 14(2):e0212907. PubMed ID: 30817783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials.
    Zannad F; Ferreira JP; Pocock SJ; Anker SD; Butler J; Filippatos G; Brueckmann M; Ofstad AP; Pfarr E; Jamal W; Packer M
    Lancet; 2020 Sep; 396(10254):819-829. PubMed ID: 32877652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the safety and efficacy of Zhenwu decoction as adjuvant therapy for the treatment of heart failure with reduced ejection fraction: A protocol for systematic review and meta-analysis.
    Han Y; Huang L; Zhong G; Chang X; Zhu Q; Xu M; Mingtai C; Men L; Wang L
    Medicine (Baltimore); 2022 Jan; 101(4):e28672. PubMed ID: 35089212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data.
    Pufulete M; Maishman R; Dabner L; Higgins JPT; Rogers CA; Dayer M; MacLeod J; Purdy S; Hollingworth W; Schou M; Anguita-Sanchez M; Karlström P; Shochat MK; McDonagh T; Nightingale AK; Reeves BC
    Syst Rev; 2018 Jul; 7(1):112. PubMed ID: 30064502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model.
    Pufulete M; Maishman R; Dabner L; Mohiuddin S; Hollingworth W; Rogers CA; Higgins J; Dayer M; Macleod J; Purdy S; McDonagh T; Nightingale A; Williams R; Reeves BC
    Health Technol Assess; 2017 Aug; 21(40):1-150. PubMed ID: 28774374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ivabradine for coronary artery disease and/or heart failure-a protocol for a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis.
    Maagaard M; Nielsen EE; Gluud C; Jakobsen JC
    Syst Rev; 2019 Feb; 8(1):39. PubMed ID: 30709418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of adding angiotensin receptor neprilysin inhibitors to usual care in patients with heart failure: a protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.
    Nielsen EE; Feinberg J; Raymond I; Olsen MH; Steensgaard-Hansen FV; Jakobsen JC
    Syst Rev; 2019 Oct; 8(1):251. PubMed ID: 31672170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary Pharmacologic Management of Heart Failure with Reduced Ejection Fraction: A Review.
    Egbuche O; Hanna B; Onuorah I; Uko E; Taha Y; Ghali JK; Onwuanyi A
    Curr Cardiol Rev; 2020; 16(1):55-64. PubMed ID: 31288726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of low blood pressure in ambulatory heart failure with reduced ejection fraction patients.
    Cautela J; Tartiere JM; Cohen-Solal A; Bellemain-Appaix A; Theron A; Tibi T; Januzzi JL; Roubille F; Girerd N
    Eur J Heart Fail; 2020 Aug; 22(8):1357-1365. PubMed ID: 32353213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of febuxostat on blood pressure in hyperuricemic patients: A protocol for a systematic review and meta-analysis.
    Yao J; Shi X; Fan S; Gao Y; Hu H; Wang P; Chen Q
    Medicine (Baltimore); 2020 Jun; 99(24):e20673. PubMed ID: 32541512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vericiguat: A Review in Chronic Heart Failure with Reduced Ejection Fraction.
    Kang C; Lamb YN
    Am J Cardiovasc Drugs; 2022 Jul; 22(4):451-459. PubMed ID: 35624347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits and adverse effects of ACE inhibitors in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis.
    Bœuf-Gibot S; Pereira B; Imbert J; Kerroum H; Menini T; Lafarge E; De Carvalho M; Vorilhon P; Boussageon R; Vaillant-Roussel H
    Eur J Clin Pharmacol; 2021 Mar; 77(3):321-329. PubMed ID: 33070218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
    Kapelios CJ; Murrow JR; Nührenberg TG; Montoro Lopez MN
    Heart Fail Rev; 2019 May; 24(3):367-377. PubMed ID: 30618017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction.
    Givertz MM; Stevenson LW; Costanzo MR; Bourge RC; Bauman JG; Ginn G; Abraham WT;
    J Am Coll Cardiol; 2017 Oct; 70(15):1875-1886. PubMed ID: 28982501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction.
    Packer M
    J Card Fail; 2019 Dec; 25(12):986-1003. PubMed ID: 31541742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.